Welcome to our dedicated page for Zentek news (Ticker: ZTEK), a resource for investors and traders seeking the latest updates and insights on Zentek stock.
Zentek Ltd (ZTEK) delivers cutting-edge innovations in healthcare technology and advanced materials through its patented intellectual property portfolio. This news hub provides investors and industry observers with timely updates on corporate developments, regulatory milestones, and commercial partnerships.
Access verified press releases and analysis covering ZenGUARD™ antimicrobial advancements, battery material research, and strategic collaborations with academic institutions. Our curated feed ensures transparent tracking of financial announcements, product launches, and intellectual property expansions.
Key updates include earnings reports, technology licensing agreements, and progress in graphite purification techniques for energy storage applications. Bookmark this page to monitor Zentek's progress in enhancing medical safety standards and sustainable material solutions.
Zentek (NASDAQ:ZTEK) announced a regulatory update regarding its ZenGUARD™ Enhanced Air Filters in Canada. Health Canada is currently evaluating the product's classification and has requested additional information from the company.
Previously, on October 31, 2024, Zentek had withdrawn its submission from the Health Canada Pest Management Regulatory Agency (PMRA) to pursue an alternative commercialization pathway. The company subsequently announced on November 27, 2024, its intention to market the air filters as a Class I medical device under its existing Medical Device Establishment License (MDEL), similar to its surgical masks.
Zentek (NASDAQ:ZTEK) has signed a three-year agency agreement with RSK Environment Ltd. on May 7, 2025, enabling RSK to market and promote ZenGUARD™ Enhanced Air Filters in over 20 countries. The partnership focuses on key global markets, including the Gulf Cooperation Council (GCC) region. Under the agreement, Zentek maintains manufacturing and fulfillment responsibilities, while RSK receives a fixed commission on sales within designated territories.
This partnership complements Zentek's existing agreements with Saudi-based Filtration Solutions Industrial Co. and Levidian, strengthening the company's presence in the GCC region. The collaboration aims to align advanced HVAC filtration solutions with regional sustainability and infrastructure objectives.
Zentek Ltd. (NASDAQ: ZTEK, TSXV: ZEN) has completed the sale of its corporate office and laboratory space property located at 24 Corporate Court in Guelph, Ontario. The transaction, which was previously announced on April 17, 2025, was finalized for a purchase price of $2.5 million. As part of the agreement, Zentek will lease back the property from the buyer until January 31, 2026, ensuring uninterrupted operations during the transition period. The company has stated that the sale will not disrupt its daily operations or affect its staff, and plans for relocation after the leaseback period will be announced in the future.
Zentek has secured a new purchase order for its ZenGUARD Enhanced Air Filters from Dexterra Group, marking a significant commercial milestone. The filters will be deployed at the Forensic Services and Coroner's Complex (FSCC) in Toronto, Ontario, where Dexterra manages integrated facility operations.
This development represents a strategic expansion of ZenGUARD's market presence, complementing two key business channels:
- An exclusive procurement opportunity with the Government of Canada
- Previously announced distribution agreements
The company views this order as an important indicator of growing ZenGUARD adoption in the Canadian market. Zentek, traded on both Nasdaq (ZTEK) and TSX-V (ZEN), continues to focus on intellectual property development and commercialization.
Zentek (NASDAQ:ZTEK) has completed the first phase of a ~$1.1 million Innovative Solutions Canada contract to develop a countermeasure for highly pathogenic avian influenza (HPAI) A(H5N1). The project, which began in November 2024, involves collaboration with McMaster University's Li Lab to create both prophylactic and therapeutic solutions using multivalent aptamer technology.
The development phase has successfully produced a lead candidate countermeasure that matched the performance of a monoclonal antibody positive control in recent in vitro neutralization experiments. The project is now moving to the testing phase, where the team will evaluate in vivo performance against H1N1 and the current H5N1 2.3.4.4b clade.
The initiative is supported by government testing partners including Health and Emergency Preparedness Canada (HERC) and Defence Research and Development Canada (DRDC), addressing the global avian influenza outbreak that has affected over 1,000 dairy cattle herds across 17 U.S. states.
Zentek (Nasdaq: ZTEK, TSXV: ZEN) has announced the sale of its corporate office and laboratory space located at 24 Corporate Court, Guelph, ON. The property will be sold for $2.5 million under an agreement dated April 15, 2025.
As part of the deal, Zentek will lease back the property until January 31, 2026, ensuring uninterrupted operations during the transition period. The company expects to complete the sale around May 15, 2025, with no anticipated disruption to daily operations or staff. The sale is part of Zentek's strategic review of its portfolio and assets to support long-term business goals.
Zentek (NASDAQ:ZTEK) has successfully completed testing of its ZenARMOR™ nano-pigment technology in military-grade, chromate-free corrosion protection aerospace paint systems under the Innovative Solutions Canada Testing Stream contract. The testing, conducted from September 2023 to July 2024, followed ASTM B117 and ASTM D5894 standards.
The final round of testing subjected samples to 2,016 hours of corrosion testing, with no obvious substrate corrosion or coating defects observed. The tests demonstrated ZenARMOR™'s effectiveness in inhibiting corrosion of aluminum alloy AA2024-T3, though control samples showed similar performance.
Additionally, Zentek announced a new collaboration with Jazeera Paints, signed January 13, 2025. The partnership aims to evaluate ZenARMOR™ nano-pigments in Jazeera's existing product lines, focusing on corrosion protection products in the Gulf Cooperation Council and Middle East and North Africa regions.
Zentek (NASDAQ:ZTEK) has signed a three-year collaboration agreement with Filtration Solutions Industrial Co. (FSCO), a Saudi-based air filtration manufacturer, to produce and distribute ZenGUARD™ Enhanced Air Filters across the Gulf Cooperation Council region.
Under the agreement effective April 11, 2025, Zentek will provide FSCO with HVAC filter media featuring their proprietary graphene-silver-based technology. The filters will be marketed throughout Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, and Oman, with revenue shared between both companies.
The ZenGUARD™ Enhanced Air Filters offer key benefits including:
- Improved viral filtration efficiency
- Reduced energy consumption through lower pressure drop
- Cost-effective protection for public buildings
- Enhanced aerosol control capabilities
Zentek (NASDAQ:ZTEK) has announced the completion of a Canada Revenue Agency (CRA) audit regarding the company's 2018 and 2019 renunciation of Canadian exploration expenses (CEE). The audit, completed on January 14, 2025, focused on flow-through common shares private placements that raised $4,210,000.
The CRA's reassessment for 2018 resulted in a reclassification of approximately $507,000 (16.895%) of renounced amounts, as they did not meet CEE definition requirements. This led to a Part XII.6 tax assessment of $59,693. A similar reclassification is expected for 2019, with details pending.
The company will indemnify affected subscribers within 20 business days for tax attributable to disallowed CEE renunciations, with maximum liability estimated at approximately $527,000. Subscribers affected by CRA reassessments are directed to contact fts@zentek.com for indemnification claims.